Effect of suturing technique on corneal xenograft survival.
OBJECTIVE
Understanding xenograft rejection is crucial for the potential introduction of xenotransplantation into clinical practice. Small-animal models play an essential role in this context and substantially contribute to our knowledge about mechanisms of xenograft rejection.


METHODS
Rat-to-mouse corneal xenografts were performed by using 2 suturing techniques. Sutures were left either as long or as short as possible to limit the extent of a nonspecific inflammatory response. Cyclosporine A (CsA), monoclonal antibody anti-T cells, and a specific inhibitor of inducible NO synthase (alone or in a combination with CsA) were tested as immunosuppressants.


RESULTS
Grafts with long sutures were rejected in 7.3 +/- 1.2 days, whereas those with short sutures were rejected after 11.8 +/- 1.0 days (P < 0.001). Similarly, long sutures induced more pronounced corneal neovascularization (P < 0.001). Although groups of recipients with long sutures all tested immunosuppressants significantly (P < 0.01-0.001) prolonged corneal graft survival, none of them showed a comparable efficacy in groups of recipients with short sutures.


CONCLUSIONS
This study showed that suturing technique significantly affects the outcome of corneal concordant xenograft transplantation, influences the effectiveness of immunosuppressive regimens, and therefore must be taken into account when evaluating their efficacy.
Sedlakova
Klara
K
Department of Ophthalmology, 1st Medical Faculty, Charles University and General Teaching Hospital, Prague, Czech Republic.
Filipec
Martin
M
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003315:Cornea / Q000502:physiology*; D016039:Corneal Transplantation; D016572:Cyclosporine / Q000627:therapeutic use; D004195:Disease Models, Animal; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D051379:Mice; D008807:Mice, Inbred BALB C; D052247:Nitric Oxide Synthase Type II / Q000037:antagonists & inhibitors; D051381:Rats; D011917:Rats, Inbred Lew; D013536:Suture Techniques; D013843:Thiazines / Q000627:therapeutic use; D018800:Thy-1 Antigens / Q000276:immunology; D014183:Transplantation, Heterologous
C093124:2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D013843:Thiazines; D018800:Thy-1 Antigens; D016572:Cyclosporine; D052247:Nitric Oxide Synthase Type II